(Q34484800)

2 August 2017

1 reference

title

Genetically engineered mice for studies of stress-related clinical conditions (English)

1 reference

2 August 2017

Marianne B Müller

1

1 reference

PubMed ID

11777495

2 August 2017

Martin E Keck

series ordinal

2

1 reference

2 August 2017

1 March 2002

1 reference

Journal of Psychiatric Research

2 August 2017

1 reference

2 August 2017

36

1 reference

2 August 2017

53-76

1 reference

2 August 2017

2

1 reference

Corticotropin releasing hormone, receptor regulation and the stress response.

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Switching on and off with RNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Effect of urocortin on ACTH secretion from rat anterior pituitary in vitro and in vivo: comparison with corticotropin-releasing hormone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Endocrine profile and neuroendocrine challenge tests in transgenic mice expressing antisense RNA against the glucocorticoid receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Corticotropin releasing factor (CRF) binding protein: a novel regulator of CRF and related peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Isolation of the human plasma corticotrophin-releasing factor-binding protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Exploring the new world of the genome with DNA microarrays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Excess corticotropin releasing hormone-binding protein in the hypothalamic-pituitary-adrenal axis in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

The new mouse genetics: altering the genome by gene targeting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Gene expression profiling: monitoring transcription and translation products using DNA microarrays and proteomics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Corticotrophin-releasing factor receptors: from molecular biology to drug design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Immunocytochemical distribution of corticotropin-releasing hormone receptor type-1 (CRF(1))-like immunoreactivity in the mouse brain: light microscopy analysis using an antibody directed against the C-terminus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

GRKO mice express an aberrant dexamethasone-binding glucocorticoid receptor, but are profoundly glucocorticoid resistant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Reduced anxiety-like and cognitive performance in mice lacking the corticotropin-releasing factor receptor 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Molecular and biochemical characterization of the mouse brain corticotropin-releasing hormone-binding protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Genetics of mouse behavior: interactions with laboratory environment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Unusual behavioral phenotypes of inbred mouse strains.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Chronic psychosocial stress enhances vasopressin, but not corticotropin-releasing factor, in the external zone of the median eminence of male rats: relationship to subordinate status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Feedback action and tonic influence of corticosteroids on brain function: a concept arising from the heterogeneity of brain receptor systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Glucocorticoid Feedback Resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Brain corticosteroid receptor balance in health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Reduced activity of hypothalamic corticotropin-releasing hormone neurons in transgenic mice with impaired glucocorticoid receptor function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Cloning and characterization of human urocortin [published erratum appears in Endocrinoogy 1996 Sep;137(9):3896]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Behavioral responses to stress are intact in CRF-deficient mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Downregulation of brain mineralocorticoid and glucocorticoid receptor by antisense oligodeoxynucleotide treatment fails to alter spatial navigation in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Glucocorticoids suppress corticotropin-releasing hormone and vasopressin expression in human hypothalamic neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Gene-targeting studies of mammalian behavior: is it the mutation or the background genotype?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Transcriptional activation by tetracyclines in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Proteomics in neuroscience: from protein to network.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Corticotropin-releasing factor CRF1, but not CRF2, receptors mediate anxiogenic-like behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Anti-sexual and anxiogenic behavioral consequences of corticotropin-releasing factor overexpression are centrally mediated.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Learning impairment in transgenic mice with central overexpression of corticotropin-releasing factor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

The corticosteroid receptor hypothesis of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Altered hypothalamic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression. Implications for pathophysiology of DST nonsuppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Genome-wide, large-scale production of mutant mice by ENU mutagenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

CRH deficiency impairs but does not block pituitary-adrenal responses to diverse stressors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Control of neuronal excitability by corticosteroid hormones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Altered anxiety and weight gain in corticotropin-releasing hormone-binding protein-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Hyperactivity of CRH neuronal circuits as a target for therapeutic interventions in affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Ageing alters intrahypothalamic release patterns of vasopressin and oxytocin in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

The anxiolytic effect of the CRH(1) receptor antagonist R121919 depends on innate emotionality in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

The corticotrophin-releasing factor-binding protein: an act of several parts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Corticotropin-releasing factor-immunoreactive neurons of the paraventricular nucleus become vasopressin positive after adrenalectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Antisense to the glucocorticoid receptor in hippocampal dentate gyrus reduces immobility in forced swim test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Molecular Identification and Analysis of a Novel Human Corticotropin-Releasing Factor (CRF) Receptor: The CRF2 Receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Glucocorticoid negative feedback selectively targets vasopressin transcription in parvocellular neurosecretory neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Distribution of urocortin-like immunoreactivity in the central nervous system of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Inducible gene targeting in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

V1 vasopressin receptor antisense oligodeoxynucleotide into septum reduces vasopressin binding, social discrimination abilities, and anxiety-related behavior in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Neuroendocrine and behavioral effects of antisense oligonucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Mice, gene targeting and behaviour: more than just genetic background

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

The Munich vulnerability study on affective disorders: overview of the cross-sectional observations at index investigation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Physiological and neurochemical aspects of corticotropin-releasing factor actions in the brain: the role of the locus coeruleus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Conditional control of gene expression in the mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Differential behavioural effects of chronic infusion of CRH 1 and CRH 2 receptor antisense oligonucleotides into the rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Chronic infusion of a CRH1 receptor antisense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Behavioral, physiological, and neuroendocrine stress responses and differential sensitivity to diazepam in two Wistar rat lines selectively bred for high- and low-anxiety-related behavior.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Long-term intracerebroventricular infusion of corticotropin-releasing hormone alters neuroendocrine, neurochemical, autonomic, behavioral, and cytokine responses to a systemic inflammatory challenge.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Impaired glucocorticoid receptor function evolves in aberrant physiological responses to bacterial endotoxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Genomics, gene expression and DNA arrays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Characterization of oligonucleotide transport into living cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Ectopic expression of the CRF-binding protein: minor impact on HPA axis regulation but induction of sexually dimorphic weight gain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Control of memory formation through regulated expression of a CaMKII transgene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

A linkage study of distal chromosome 5q and bipolar disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Corticosteroid receptor function is decreased in depressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Hormonal response pattern in the combined DEX-CRH test is stable over time in subjects at high familial risk for affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Long-term antidepressant treatment reduces behavioural deficits in transgenic mice with impaired glucocorticoid receptor function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Ain't misbehavin'--it's genetic!

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Differential distribution of urocortin- and corticotropin-releasing factor-like immunoreactivities in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Genome-wide search for linkage of bipolar affective disorders in a very large pedigree derived from a homogeneous population in quebec points to a locus of major effect on chromosome 12q23-q24

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Glucocorticoid receptor alpha and beta isoforms are not mutated in bipolar affective disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Impaired diurnal adrenal rhythmicity restored by constant infusion of corticotropin-releasing hormone in corticotropin-releasing hormone-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Vasopressin, major depression, and hypothalamic-pituitary-adrenocortical desensitization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Disruption of feeding behavior in CRH receptor 1-deficient mice is dependent on glucocorticoids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Expression of CRHR1 and CRHR2 in mouse pituitary and adrenal gland: implications for HPA system regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Ten years of gene targeting: targeted mouse mutants, from vector design to phenotype analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Antisense RNA production in transgenic mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Sensible use of antisense: how to use oligonucleotides as research tools

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Modifier genes in mice and humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Cre recombinase: The universal reagent for genome tailoring

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

The use of genetic "knockout" mice in behavioral endocrinology research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Antisense oligonucleotides in neuroendocrinology: enthusiasm and frustration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Selective corticosteroid antagonists modulate specific aspects of spatial orientation learning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Point mutation in the mouse glucocorticoid receptor preventing DNA binding impairs spatial memory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Spatial learning deficits in mice with a targeted glucocorticoid receptor gene disruption.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Proteomics to study genes and genomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Impaired type II glucocorticoid-receptor function in mice bearing antisense RNA transgene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Glucocorticoids as a biological substrate of reward: physiological and pathophysiological implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Cloning and characterization of the cDNAs for human and rat corticotropin releasing factor-binding proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

The central distribution of a corticotropin-releasing factor (CRF)-binding protein predicts multiple sites and modes of interaction with CRF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

DNA binding of the glucocorticoid receptor is not essential for survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Two receptor systems for corticosterone in rat brain: microdistribution and differential occupation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Altered neuroimmunoendocrine communication during a condition of chronically increased brain corticotropin-releasing hormone drive.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Urocortin II: a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Interaction of Corticotropin-Releasing Factor and Arginine Vasopressin on Adrenocorticotropin Secretionin Vivo*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Modulation of stress-induced ACTH release by corticotropin-releasing factor, catecholamines and vasopressin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Spatial memory in transgenic mice with impaired glucocorticoid receptor function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Neuroendocrine aspects of primary endogenous depression. I. Cortisol secretory dynamics in patients and matched controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Intracerebral administration of mineralocorticoid receptor antisense oligonucleotides attenuate adrenal steroid-induced salt appetite in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Inducible gene targeting in mice using the Cre/lox system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Induction of corticotropin-releasing hormone gene expression by glucocorticoids: implication for understanding the states of fear and anxiety and allostatic load.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Enhanced morphine-induced behavioural effects and dopamine release in the nucleus accumbens in a transgenic mouse model of impaired glucocorticoid (type II) receptor function: influence of long-term treatment with the antidepressant moclobemide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Mutant Mice and Neuroscience: Recommendations Concerning Genetic Background

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Corticotropin-releasing factor is a potent inhibitor of sexual receptivity in the female rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Chronic administration of the triazolobenzodiazepine alprazolam produces opposite effects on corticotropin-releasing factor and urocortin neuronal systems.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Corticotropin-releasing hormone receptor (type I) antisense targeting reduces anxiety.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide induces anxiolytic effects in rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide treatment attenuates social defeat-induced anxiety in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Vasopressin antisense oligonucleotide induces temporary diabetes insipidus in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Hippocampal mineralocorticoid, but not glucocorticoid, receptors modulate anxiety-like behavior in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Morphine-induced locomotor and neurochemical stimulation is enhanced in transgenic mice with impaired glucocorticoid receptor function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Appetite-suppressing effects of urocortin, a CRF-related neuropeptide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Dexamethasone nonsuppression in transgenic mice expressing antisense RNA to the glucocorticoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Enhanced conditioned approach responses in transgenic mice with impaired glucocorticoid receptor function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Effects of the monoamine oxidase A inhibitor moclobemide on hippocampal plasticity in GR-impaired transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Disrupted allocentric but preserved egocentric spatial learning in transgenic mice with impaired glucocorticoid receptor function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Glucocorticosteroid resistance in humans. Elucidation of the molecular mechanisms and implications for pathophysiology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus: a hybridization histochemical study in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Amygdaloid corticotropin-releasing factor targets locus coeruleus dendrites: substrate for the co-ordination of emotional and cognitive limbs of the stress response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Physiological role of corticotropin-releasing factor in the control of adrenocorticotropin-mediated corticosterone release from the rat adrenal gland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Transport of oligonucleotides across natural and model membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Combined administration of human corticotropin-releasing factor and lysine vasopressin induces cortisol escape from dexamethasone suppression in healthy subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

The impact of physiological stimuli on the expression of corticotropin-releasing hormone (CRH) and other neuropeptide genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Antisense strategies in neurobiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

CRH-deficient mice have a normal anorectic response to chronic stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Stress-induced behaviors require the corticotropin-releasing hormone (CRH) receptor, but not CRH.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Molecular basis of glucocorticoid-resistant syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Effects of a novel corticotropin-releasing-hormone receptor type I antagonist on human adrenal function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Release of vasopressin within the rat paraventricular nucleus in response to emotional stress: a novel mechanism of regulating adrenocorticotropic hormone secretion?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Mechanism of oligonucleotide uptake by cells: involvement of specific receptors?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Urocortin-like immunoreactivity in the substantia nigra, ventral tegmental area and Edinger-Westphal nucleus of rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Gene targeting and behaviour: a genetic problem requires a genetic solution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

Prediction of medium-term outcome by cortisol response to the combined dexamethasone-CRH test in patients with remitted depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2801%2900049-8

10.1016/S0022-3956(01)00049-8

7 January 2021

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

11777495